SI-BONE, Inc. (SIBN)
18.30
-0.12
(-0.62%)
USD |
NASDAQ |
Sep 10, 16:00
18.30
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Shareholders Equity (Quarterly) : 182.35M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 182.35M |
| March 31, 2026 | 178.94M |
| December 31, 2025 | 177.53M |
| September 30, 2025 | 172.13M |
| June 30, 2025 | 170.34M |
| March 31, 2025 | 167.26M |
| December 31, 2024 | 166.96M |
| September 30, 2024 | 164.97M |
| June 30, 2024 | 164.73M |
| March 31, 2024 | 165.54M |
| December 31, 2023 | 169.38M |
| September 30, 2023 | 173.60M |
| June 30, 2023 | 177.41M |
| March 31, 2023 | 93.96M |
| December 31, 2022 | 98.30M |
| September 30, 2022 | 102.83M |
| June 30, 2022 | 110.83M |
| March 31, 2022 | 122.44M |
| December 31, 2021 | 134.42M |
| September 30, 2021 | 143.62M |
| June 30, 2021 | 154.20M |
| March 31, 2021 | 161.67M |
| December 31, 2020 | 169.36M |
| September 30, 2020 | 102.03M |
| June 30, 2020 | 107.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 116.27M |
| December 31, 2019 | 63.01M |
| September 30, 2019 | 68.96M |
| June 30, 2019 | 77.75M |
| March 31, 2019 | 82.76M |
| December 31, 2018 | 90.19M |
| September 30, 2018 | -20.88M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -10.83M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 4.226M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.617M |
| December 31, 2014 | 7.223M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 248.76M |
| Total Liabilities (Quarterly) | 66.41M |
| Debt to Equity Ratio | 0.2347 |
| Current Ratio | 9.147 |
| Net Debt Paydown Yield | -0.15% |